Clinical Trials
18 trialsNCT07554885 2026-05-26
Nutritional + Usual Corticosteroids Randomized Trial for Immune-Related pneumoniA - Therapeutic Utilization Evaluation
Guangzhou Institute of Respiratory Disease
Phase NA Not yet recruiting
NCT07008027 2026-05-22
Real World Asparaginase Therapy Toxicity
St. Jude Children's Research Hospital
Not yet recruiting
NCT07582887 2026-05-13
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Recruiting
NCT04659343 2026-05-04
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
Recruiting
NCT05838638 2026-05-01
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
University of Central Florida
Phase NA Recruiting
NCT07354971 2026-04-28
IMMUNO-FIT Observational Study
University Hospital Southampton NHS Foundation Trust
Recruiting
NCT00093353 2026-04-14
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
NCT05096338 2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT00400946 2026-02-13
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Dana-Farber Cancer Institute
Phase 3 Completed
NCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT05512169 2026-01-15
MPGx-INDALL
University of Geneva, Switzerland
Recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT07264985 2025-12-04
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Hubei Cancer Hospital
Not yet recruiting
NCT07237906 2025-11-20
Neutropenia With TNF-α Inhibitors
Istanbul University - Cerrahpasa
Completed
NCT05078190 2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT06726590 2025-09-12
IPGx Registry
Texas A&M University
Recruiting
NCT07063706 2025-07-18
Pharmaceutical Care for Patients Using Capecitabine
Faculdade de Farmácia
Phase NA Completed
NCT06789601 2025-06-19
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Brigham and Women's Hospital
Phase 1/2 Recruiting